How should marketers position this new type of cancer therapy?
Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.
The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.
Linda Ruschau, chief client officer of PatientPoint, talks with Larry Dobrow, senior editor at MM&M, about how to better engage with HCPs. The questions and topic were created and selected by the MM&M editorial staff. The video is sponsored by PatientPoint.
FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified
Outcome Health reportedly misled advertisers; FDA committee recommends gene therapy; Avanir drug is highly prescribed by docs paid by company
Merck scraps plans for cholesterol drug; oncologist describes how he tells people about his work; researchers question list of side effects in DTC ads
Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.
Pfizer considers sale of its consumer healthcare business; Express Scripts moves into patient benefit management; China to speed up drug approvals
Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California
The communications team, led by Jeff Winton, is again researching Astellas' reputation for an updated picture on where the campaign has gotten them so far.
AbbVie to pay $140 million to AndroGel patient; Trump likely to roll back birth-control mandate; patients more likely to respond to expensive drugs
Cigna will no longer cover OxyContin; the AMA no longer supports price-fixing to lower drug prices; Gottlieb is not in favor of 'right-to-try' laws
In the 2015-16 flu season, more than 145 million doses were distributed by manufacturers, according to the Centers for Disease Control and Prevention, but only 41% of American adults received a vaccine.
The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%
DKMS worked with Marino on PR for the campaign and with Area 23 on its Comic Con booth.
The top three most advertised brands were GlaxoSmithKline's Breo Ellipta, Eli Lilly's Trulicity, and Boehringer Ingelheim's Jardiance.
The FDA wants to improve the generic drug approval process; Allergan CEO responds to criticism of patent deal; breast cancer death rate dropped 40%
The successes of these pharma execs show that there's no one path to professional bliss.